# PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients

> **NCT01373684** · PHASE4 · COMPLETED · sponsor: **Foundation for Liver Research** · enrollment: 90 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Peginterferon alfa-2a
- **DRUG:** Nucleos(t)ide analogue

## Key facts

- **NCT ID:** NCT01373684
- **Lead sponsor:** Foundation for Liver Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-25
- **Primary completion:** 2019-10-28
- **Final completion:** 2019-10-28
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2019-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01373684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01373684, "PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01373684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*